BIOTECNOLOGÍA DE NUTRACÉUTICOS Y COMPUESTOS BIOACTIVOS
BIONUC
Universitat Politècnica de Catalunya
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Politècnica de Catalunya (9)
2023
-
Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma
Redox Biology, Vol. 62
-
Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells
Free Radical Biology and Medicine, Vol. 209, pp. 127-134
2022
-
Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer
Free Radical Biology and Medicine, Vol. 189, pp. 32-41
2021
-
Cold atmospheric plasma: A new strategy based primarily on oxidative stress for osteosarcoma therapy
Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-29
-
Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures
Nature Protocols, Vol. 16, Núm. 6, pp. 2826-2850
-
Mithramycin delivery systems to develop effective therapies in sarcomas
Journal of Nanobiotechnology, Vol. 19, Núm. 1
-
Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties
Free Radical Biology and Medicine, Vol. 164, pp. 107-118
2020
-
Cold plasma-treated ringer’s saline: A weapon to target osteosarcoma
Cancers, Vol. 12, Núm. 1
2019
-
Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma
Scientific Reports, Vol. 9, Núm. 1